ClinicalTrials.gov
public full text
Public Domain
Comparing ARNI With ACE Inhibitor on Endothelial Function
PARADOR is multisite, randomized, double-blind, phase IV clinical trial to compare the effect of sacubitril/valsartan (Entresto™) to enalapril (Vasotec®) on blood vessel function in subjects with heart failure with reduced ejection fraction (HFREF).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for Hypertension#123610
- Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF#1072210
- Carnitine for the Treatment of Atherosclerosis.#125975
- Noninvasive Pulse Contour Analysis for Hemodynamic Assessment in Patients With Chronic Heart Failure#877249
- South Korean Pitavastatin Heart Failure Study#899438
Record · ID 1085614
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive